Amoxicillin + Clavulanic acid
Amoksiklav Amoksiklav 2x 1000 mgare different trade names for the same medicine.
Amoksiklav is an antibiotic that kills bacteria that cause infections. It contains two different medicines: amoxicillin and clavulanic acid. Amoxicillin belongs to a group of medicines called penicillins, whose action can sometimes be inhibited (inactivated). The second active substance (clavulanic acid) counteracts this inactivation.
Amoksiklav is used in adults and children to treat the following infections:
→ If any of the above situations apply to the patient, they should not take Amoksiklav.
In case of doubt, consult a doctor or pharmacist before taking Amoksiklav.
Before taking this medicine, the patient should discuss it with their doctor or pharmacist if they:
In case of doubt, whether any of these statements apply to the patient, they should consult their doctor or pharmacist before taking the medicine.
In some cases, the doctor may examine what type of bacteria caused the infection. Depending on the test results, the patient may receive Amoksiklav with a different strength or a different medicine.
Taking Amoksiklav may worsen the course of some existing diseases or cause severe side effects (such as allergic reactions, seizures, and colitis). To minimize the risk of any problems, while taking Amoksiklav, the patient should pay attention to whether certain symptoms occur (see "Conditions to watch out for" in section 4).
If the patient is to have a blood test (e.g., red blood cell test or liver function tests) or a urine test (for glucose), they should inform their doctor or nurse that they are taking Amoksiklav. The medicine may affect the results of these tests.
The patient should tell their doctor or pharmacist about all medicines they are currently taking, or have recently taken, as well as any medicines they plan to take, including those that are available without a prescription and herbal medicines.
If the patient is taking allopurinol (used to treat gout), the likelihood of a skin allergic reaction increases.
If the patient is taking probenecid (used to treat gout), the doctor may decide to modify the dose of Amoksiklav.
If the patient is taking medicines that reduce blood clotting (such as warfarin), additional blood tests may be necessary.
Amoksiklav may affect the action of methotrexate (a medicine used to treat cancer or rheumatic diseases).
If the patient is receiving mycophenolate mofetil (a medicine used to prevent organ rejection), while taking Amoksiklav, the doctor will closely monitor their health.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine.
Amoksiklav may cause side effects and symptoms that disrupt the ability to drive vehicles. The patient should not drive vehicles or operate machinery unless they feel well.
This medicine contains less than 1 mmol (23 mg) of sodium per film-coated tablet, which means the medicine is considered "sodium-free".
The medicine contains 24 mg of potassium, i.e., less than 1 mmol (or 39 mg) per film-coated tablet. The medicine contains 1.85 mmol (72 mg) of potassium per maximum daily dose, which should be taken into account in patients with reduced kidney function and in patients controlling their potassium intake.
This medicine should always be taken as directed by the doctor. In case of doubt, consult a doctor or pharmacist.
Children under 6 years of age should preferably receive Amoksiklav in the form of an oral suspension.
Before taking Amoksiklav tablets in children with a body weight of less than 40 kg, consult a doctor or pharmacist.
If the patient has taken a higher dose of Amoksiklav than recommended, they may experience symptoms such as stomach and intestinal irritation (nausea, vomiting, or diarrhea) or seizures. They should contact their doctor as soon as possible. They should take the packaging of the medicine with them to show the doctor.
If the patient forgets to take a dose, they should take it as soon as they remember. They should not take the next dose too soon, but wait about 4 hours before taking it.
The patient should take Amoksiklav until the end of the treatment, even if they feel better. All doses of the medicine are needed to combat the infection. If some bacteria survive, they may cause a recurrence of the infection.
In case of any further doubts about taking this medicine, consult a doctor or pharmacist.
Like all medicines, Amoksiklav can cause side effects, although not everybody gets them.
→ If the patient experiences any of these symptoms, they should contact their doctor immediately.
Colitis, causing watery diarrhea, usually with blood and mucus, abdominal pain, and (or) fever.
→ If the patient experiences any of these symptoms, they should consult their doctor as soon as possible for advice.
Very common side effects (occurring in more than 1 in 10 people)
Common side effects (occurring in less than 1 in 10 people but more than 1 in 100 people)
Uncommon side effects that may appear in blood test results:
Rare side effects (occurring in less than 1 in 1000 people but more than 1 in 10,000 people)
Rare side effects that may appear in blood test results:
Other side effects have occurred in a very small number of people, but their exact frequency is not known:
→ If the patient experiences any of the above symptoms, they should contact their doctor immediately.
Side effects that may appear in blood test results:
If side effects occur, including any not listed in this leaflet, the patient should tell their doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Drug Safety, Ministry of Health, via the website: https://smz.ezdrowie.gov.pl
Reporting side effects will help to gather more information on the safety of this medicine.
The 625 mg film-coated tablets are white or almost white, oval, with sharp edges, marked with 875/125 on one side and AMC on the other, in Al/Al blisters. Each packaging contains 14 tablets.
For more detailed information, consult the marketing authorization holder or parallel importer.
Lek Pharmaceuticals d.d.
Verovškova 57
1526 Ljubljana, Slovenia
Lek Pharmaceuticals d.d.
Verovškova 57
1526 Ljubljana, Slovenia
Lek Pharmaceuticals d.d.
Perzonali 47
SI-2391 Prevalje, Slovenia
Parallel importer:
PharmaVitae Sp. z o.o. Sp. k., ul. E. Orzeszkowej 3/35, 59-820 Leśna
Repackaged by:
Pharma Innovations Sp. z o.o., ul. Jagiellońska 76, 03-301 Warszawa
Synoptis Industrial Sp. z o.o., ul. Szosa Bydgoska 58, 87-100 Toruń
Prespack Jacek Karoński, ul. Św. Wawrzyńca 34, 60-541 Poznań
CEFEA Sp. z o.o. sp. komandytowa, ul. Działkowa 56, 02-234 Warszawa
Authorization number in Romania, the country of export: 6354/2006/02
Parallel import authorization number: 92/17
Date of leaflet approval: 22.03.2022
[Information about the trademark]
Antibiotics are used to treat bacterial infections. They are ineffective in treating viral infections.
Sometimes, bacterial infections do not respond to antibiotic treatment.
One of the most common reasons for this phenomenon is that the bacteria are resistant to the administered antibiotic.
This means that the bacteria can survive or multiply despite the use of the antibiotic.
Bacteria can become resistant to antibiotics for many reasons. Careful use of antibiotics can help reduce the possibility of bacteria developing resistance.
The antibiotic prescribed by the doctor is intended solely for the treatment of the current illness. Paying attention to the following tips will help prevent the development of resistant bacteria that could hinder the action of the antibiotic.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.